Paralysis periodica paramyotonica. A clinical and neurophysiological study.
D000086:Acetazolamide; D000109:Acetylcholine; D000328:Adult; D000410:Alanine Transaminase / Q000378:metabolism; D001219:Aspartate Aminotransferases / Q000378:metabolism; D002118:Calcium / Q000097:blood; D003402:Creatine Kinase / Q000378:metabolism; D004491:Edrophonium; D004562:Electrocardiography; D004569:Electroencephalography; D004576:Electromyography; D005221:Fatigue; D006801:Humans; D007677:Kidney Function Tests; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009046:Motor Neurons; D009119:Muscle Contraction; D009132:Muscles / Q000201:enzymology / Q000503:physiopathology*; D009224:Myotonia Congenita / Q000201:enzymology / Q000235:genetics* / Q000503:physiopathology; D009388:Neostigmine; D010507:Periodicity; D010672:Phenytoin; D005082:Physical Exertion; D011188:Potassium; D011342:Procainamide; D009435:Synaptic Transmission; D013960:Thyroid Function Tests
D009388:Neostigmine; D010672:Phenytoin; D004491:Edrophonium; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D003402:Creatine Kinase; D011342:Procainamide; D000109:Acetylcholine; D000086:Acetazolamide; D011188:Potassium; D002118:Calcium